Manufacture Supply. 4.1 ASLAN agrees to provide clinical drug supplies to BIOGENETICS required for Regulatory Filings by or on behalf of BIOGENETICS and for Commercialisation of Products, pursuant to a separate manufacturing and supply agreement to be negotiated in good faith by the Parties and which the Parties shall use Commercially Reasonable Efforts to enter into no later than 30th June 2020.
Manufacture Supply. 10.1 Supply for Sublicensee’s pre-clinical and clinical activities.
Manufacture Supply. Bionutrics shall have the right to manufacture or supply the Products or to have the Products manufactured and supplied by an Affiliate of Bionutrics; provided that the cost of goods for Products manufactured by Bionutrics or such Affiliate is competitive with the cost of goods for the Product as and if manufactured by a qualified third party manufacturer. Alternatively, Bionutrics shall have the right to contract with a suitable third party to manufacture and supply Bionutrics’ requirements for commercial supplies of the Products. Upon request Nostrum shall cooperate with Bionutrics in transferring and implementing the Nostrum Technology and Formulations related to the manufacture of the Products to the site Bionutrics chose for the manufacture of the Products in accordance with FDA guidelines applicable to the proposed transfer. Bionutrics shall reimburse Nostrum within thirty (30) days of Bionutrics’ receipt of Nostrum’s invoices for all reasonable out-of-pocket expenses which Nostrum may incur in connection with the performance of its obligations pursuant to this Section.
Manufacture Supply. Synovics Labs shall have the right to contract directly with a suitable third party to manufacture and supply Synovics Labs' requirements for commercial supplies of the Product. Alternatively, Synovics Labs may elect to have the Product manufactured and supplied by itself or one of its Affiliates; provided that the cost of goods for Product manufactured by Synovics Labs or such Affiliate is competitive with the cost of goods for the Product as manufactured by a qualified third party manufacturer. Upon request, Nostrum shall cooperate with Synovics Labs in transferring and implementing the Nostrum Technology related to manufacture of the Product from one site of manufacture for the Product to another in accordance with FDA guidelines applicable to the proposed transfer. Synovics Labs shall reimburse Nostrum within thirty (30) days of Synovics Labs' receipt of Nostrum's invoice(s) for all reasonable out-of-pocket expenses which Nostrum may incur in connection with the performance of its obligations pursuant to this Section 3.6.
Manufacture Supply
